Three-month repeated oral dose toxicity study of garenoxacin in cynomolgus monkeys

Japanese Journal of Chemotherapy

Volumn 55, Issue SUPPL. 1, 2007, Pages 42-53

  Kizawa, Kazuo ^a   Fukumoto, Hiroyuki ^a   Sanzen, Takahiro ^a   Tsusaki, Hideshi ^b   Todo, Yozo ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

Des fluoro(6) quinolone; Garenoxacin; Monkey; Subacute toxicity

Indexed keywords

GARENOXACIN; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEEDING; FEMALE; FOOD INTAKE; HEARING; HEMATOLOGY; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; MALE; MAXIMUM PLASMA CONCENTRATION; MONKEY; NONHUMAN; OPHTHALMOLOGY; SALIVATION; STOMACH DISEASE; STOMACH FUNDUS; TREATMENT DURATION; URINALYSIS; VOMITING;

EID: 35348946464     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Takahata M, Mitsuyama J, Yamashiro Y, Yonezawa M, Araki H, Todo Y, et al: In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother 1999; 43: 1077-84
2. Fung-Tomc J C, Minassian B, Kolek B, Huczko E, Aleksunes L, Stickle T, et al: Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob Agents Chemother 2000; 44: 3351-6
3. Japanese source.
4. von Keutz E, Schlüter G: Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone. J Antimicrob Chemother 1999; 43(Suppl B): 91-100
5. Kato M, West H A, Ashby R, Virgo D M, Fowler J S, Furuhama K, et al: Four-week sub-acute toxicity study of S-(-)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido- [1,2,3,-de] [1, 4] benzoxazine-6-carboxylic acid hemihydrate (DR-3355) in CD rats and cynomolgus monkeys. J Toxicol Sci 1991; 16: 29-48
6. Japanese source.
7. Japanese source.
8. Japanese source.
9. Japanese source.
10. Japanese source.
11. Ball P: Adverse drug reactions: implications for the development of fluoroquinolones. J Antimicrob Chemother 2003; 51 (Suppl 1): 21-7
12. Japanese source.
13. Japanese source.